BK and JC virus: A review

Journal of Infection

Volumn 68, Issue SUPPL1, 2014, Pages

  Pinto, Michelle ^a   Dobson, Simon ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

Author keywords

BK Virus; JC Virus; Polyomavirus

Indexed keywords

CIDOFOVIR; CYTARABINE; DIURETIC AGENT; GATIFLOXACIN; IMMUNOGLOBULIN G; LEFLUNOMIDE; MIRTAZAPINE; VIRUS T ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANALGESIA; ARTICLE; BK VIRUS; BLADDER IRRIGATION; BRAIN BIOPSY; CEREBROSPINAL FLUID ANALYSIS; COLORECTAL CANCER; CYTOMEGALOVIRUS RETINITIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; HEMATOLOGIC MALIGNANCY; HEMORRHAGIC CYSTITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDRATION; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; JC VIRUS; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; LIVER DISEASE; LOW DRUG DOSE; MENINGOENCEPHALITIS; NEUROIMAGING; NONHUMAN; PNEUMONIA; PREVALENCE; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RETINITIS; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; URETER OBSTRUCTION; URINALYSIS; VIRAL CLEARANCE; VIRAL UPPER RESPIRATORY TRACT INFECTION; VIREMIA; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS REACTIVATION;

BK VIRUS; JC VIRUS; POLYOMAVIRUS;

BK VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; JC VIRUS; POLYOMAVIRUS INFECTIONS; VIRUS ACTIVATION;

EID: 84889683190     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.09.009     Document Type: Article

References (85)

1. Killham L. Isolation in suckling mice of a virus from C3H mice harbouring Bittner milk agent. Science 1952, 116(3015):391-392.
2. Gross L. A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc Soc Exp Biol Med 1953, 83(2):414-421.
3. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319(5866):1096-1100.
4. Neu U., Stehle T., Atwood W.J. The Polyomaviridae: contributions of virus structure to our understanding of virus receptors and infectious entry. Virology 2009, 384(2):389-399.
5. Gardner S.D., Field A.M., Coleman D.V., Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971, 1(7712):1253-1257.
6. Padgett B.L., Walker D.L., ZuRhein G.M., Eckroade R.J., Dessel B.H. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971, (7712):1257-1260.
7. Allander T., Andreasson K., Gupta S., Bjerkner A., Bogdanovic G., Persson M.A., et al. Identification of a third human polyomavirus. J Virol 2007, 81(8):4130-4136.
8. Gaynor A.M., Nissen M.D., Whiley D.M., Mackay I.M., Lambert S.B., Wu G., et al. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog 2007, 3(5):e64.
9. van der Meijden E., Janssens R.W., Lauber C., Bouwes Bavnick J.N., Gorbalenya A.E., Feltkamp M.C. Discovery of spinulosa in an immunocompromized patient. PLoS Pathog 2010, 6:e1001024.
10. Tan C.S., Koralnik I.J. JC, BK, and other polyomaviruses: progressive multifocal leukoencephalopathy. Principles and practices of infectious diseases 2009, Churchill Livingstone, Philadelphia. 10th ed. G.L. Mandell (Ed.).
11. Eash S., Manley K., Gasparovic M., Querbes W., Atwood W.J. The human polyomaviruses. Cell Mol Life Sci 2006, 63(7-8):865-876.
12. Boothpur R., Brennan D.C. Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol 2010, 47:306-312.
13. Imperiale M. The human polyomaviruses: an overview 2001, Wiley-Liss, Wilmington.
14. Tsai B., Gilbert J.M., Stehle T., Lencer W., Benjamin T.L., Rapoport T.A. Gangliosides are receptors for murine polyoma virus and SV40. EMBO J 2003, 22(17):4346-4355.
15. Low J.A., Mangnuson B., Tsai B., Imperiale M.J. Identification of gangliosides GD1b and GT1b as receptors for BK virus. J Virol 2006, 80(3):1361-1366.
16. Dugan As, Eash S., Atwood W.J. An N-linked glycoprotien with alpha(2,3)-linked sialic acid is a receptor for BK virus. J Virol 2005, 79(22):14442-14445.
17. Elphick G.F., Querbes W., Jordan J.A., Gee G.V., Eash S., Manley K., et al. the human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004, 306(5700):1380-1383.
18. Kasamatsu H., Nakanishi A. How do animal DNA viruses get to the nucleus?. Annu Rev Microbiol 1998, 52:627-686.
19. Bonfill-Mas S., Formiga-Cruz M., Clemente-Casares P., Calafell F., Girones R. Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. J Virol 2001, 75(21):10290-10299.
20. Monaco M.C., Jensen P.N., Hou J., Durham L.C., Major E.O. Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol 1998, 72(12):9918-9923.
21. Taguchi F., Nagaki D., Saito M., Haruyama C., Iwasaki K. Transplancental transmission of BK virus in human. Jpn J Microbiol 1975, 19(5):395-398.
22. Bohl D.L., Storch G.A., Ryschkewitsch C., Gaudreault-Keener M., Schnitzler M.A., Major E.O., et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005, 5(9):2213-2221.
23. Tan C.S., Dezube B.J., Bhargava P., Autissier P., Wuthrich C., Miller J., et al. Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J Infect Dis 2009, 199:881-888.
24. Padgett B.L., Walker D.L. Prevalence of antibodies in human sero against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis 1973, l27:467-470.
25. Shah K.V., Daniel R.W., Warszawski R.M. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973, 128:784-787.
26. Vanchiere J.A. Human polyomaviruses. Feigin and Cherry's textbook of pediatric infectious diseases 2009, Saunders/Elsevier, Philadelphia. 6th ed. R.D. Feigin (Ed.).
27. Arthur R.R., Shah K.V. Occurrence and significance of papovaviruses BK and JC in the urine. Prog Med Virol 1989, 36:42-61.
28. Wong A.S., Chan K.H., Cheng V.C., Yuen K.Y., Kwong Y.L., Leung A.Y. Relationship of pretransplantation polyoma BK virus serologic findings and BK viral reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2007, 44:830-837.
29. Nickeleit V., Hirsch H.H., Zeiler M., Gudat F., Prince O., Thiel G., et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000, 15:324-332.
30. Koukonlaki M., Grispou E., Pistoulas D., Balaska K., Apostolou T., Anagnostopoulou M., et al. Prospective monitoring of BK virus replication in renal transplant recipients. Transpl Infect Dis 2009, 11:1-10.
31. Nickeleit V., Klimkait T., Binet I.F., Dalguen P., Del Zenero V., Thiel G., et al. Testing for polyomavirus type BK DNA in plasma to identify renal allograft recipients with viral nephropathy. N Engl J Med 2000, 342:1309-1315.
32. Cinque P., Koralnik I.J., Clifford D.B. The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology. J Nerovirol 2003, 9(Suppl. 1):88-92.
33. Kuypers D.R., Vandooren A.K., Lerut E., Evenepoel P., Claes K., Snoeck R., et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus intersitital nephritis in renal transplant recipients. Am J Transplant 2005, 5(8):1997-2004.
34. Josephson M.A., Gillen D., Javaid B., Kadambi P., Meehan S., Foster P., et al. Treatment of renal allograft polyoma BK virus infection with lefunomide. Transplantation 2006, 8(5):704-710.
35. Power C., Gladden J.G., Halliday W., Del Bigio M.R., Nath A., Ni W., et al. AIDS- and non-AIDS-related PML association with distinct p53 polymorphism. Neurology 2000, 54:743-746.
36. Berger J.R., Kaszovitz B., Post M.J., Dickenson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with report of sixteen cases. Ann Intern Med 1987, 107:78-87.
37. Koralnik I.J., Schellingerhout D., Frosch M.P. Case records of the Massechusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficits. N Engl J Med 2004, 350:1882-1893.
38. Bressollette-Bodin C., Coste-Burel M., Hourmant M., Sebille V., Andre-Garnier E., Imbert-Marcille B.M. A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant 2005, 5(8):1926-1933.
39. Brennan D.C., Agha I., Bohl D.L., Schnitzler M.A., Hardinger K.L., Lockwood M., et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005, 5(3):582-594.
40. Vasudev B., Hariharan S., Hussain S.A., Zhu Y.R., Bresnahan B.A., Cohen E.P. BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005, 68:1834-1839.
41. Dall A., Hariharan S. BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol 2008, 3:S68-S75.
42. Binet I., Nickeleit V., Hirsch H.H., Prince O., Dalguen P., Gudat F., et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 1999, 67(6):918-922.
43. Hirsch H.H. Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation. Am J Transplant 2002, 2(1):25-30.
44. Hirsch H.H. BK virus: opportunity makes a pathogen. Clin Infect Dis 2005, 41(3):354-360.
45. Egli A., Binggeli S., Bodaghi S., Dumoulin A., Funk G.A., Khanna N., et al. Cytomegalovirus and polyomavirus BK posttransplant. Nephrol Dial Transplant 2007, 22(Suppl. 8):872-882.
46. Azzi A., Cesaro S., Laszlo D., Zakrzewska K., Ciappi S., De Santis R., et al. Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. J Clin Virol 1999, 14:79-86.
47. Leung A.Y., Yuen K.Y., Cheng V.C., Lie A.K., Liang R., Kwong Y.L. Clinical characteristics of and risk factors for herpes zoster after hematopoietic stem cell transplantation. Haematologica 2002, 87:444-446.
48. Reploeg M.D., Storch G.A., Clifford D.B. BK virus: a clinical review. Clin Infect Dis 2001, 33:191-202.
49. Hedquist B.G., Bratt G., Hammarin A.L., Grandien M., Nennesmo I., Sundelin B., et al. Identification of BK virus in a patient with acquired immune deficiency syndrome and bilateral atypical retinitis. Ophthamology 1999, 106:129-132.
50. O'Reilly R.J., Lee F.K., Grossbard E., Kapoor N., Kirkpatrick D., Dinsmore R., et al. Papovavirus excretion following marrow transplantation: incidence and association with hepatic dysfunction. Transplant Proc 1981, 13:262-266.
51. Ballbrach A., Lohler J., Gossmann J., Gluck T., Petersen D., Gerth H.J., et al. Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol 1993, 143:29-39.
52. Bratt G., Hammarin A.L., Grandien M., Hedquist B.G., Nennesmo I., Sundelin B., et al. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS 1999, 13:1701-1705.
53. Hammarin A.L., Bogdanovic G., Svedhem V., Perskanen R., Morfeldt L., Grandien M. Analysis of PCR as a tool for detection of JC virus DNA in cerebrospinal fluid for diagnosis of progressive multifocal leukoencephalopathy. J Clin Microbiol 1996, 34:2929-2932.
54. Lima M.A., Dislane F.W., Koralnik I.J. Seizures and their outcome in progressive multifocal leukoencephalopathy. Neurology 2006, 66:262-264.
55. Marzocchetti A., Lima M., Tompkins T., Kavanagh D.G., Gandhi R.T., O'Neill D.W., et al. Efficient invitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy. Virology 2009, 383:173-177.
56. Erard V., Boeckh M. BK, JC and other human polyomaviruses. Principles and practice of pediatric infectious disease 2012, Churchill Livingstone, Philadelphia. 4th ed. S. Long (Ed.).
57. Coelho T.R., Almeida L., Lazo P.A. JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process?. Virol J 2010, 7:42-49.
58. Haggerty S., Walker D.L., Frisque R.J. JC virus-simian virus 40 genomes containing heterologous regulatory signals and chimeric early regions: identification of regions restricting transformation by JC virus. J Virol 1989, 63:2180-2190.
59. Burnett-Hartman A.N., Newcomb P.A., Potter J.D. Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus and human papillomavirus. Cancer Biomarkers Prev 2008, 17:2970-2979.
60. Niv Y., Goel A., Boland C.R. JC virus and colorectal cancer: a possible trigger in the chromosomal instability pathways. Curr Opin Gastroenterol 2005, 21:87-95.
61. Nosho K., Shima K., Kure S., Irahara N., Baba Y., Chen L., et al. JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype. Neoplasia 2009, 11:87-95.
62. Hori R., Murai Y., Tsuneyama K., Abdel-Aziz H.O., Nomoto K., Takahashi H., et al. Detection of JC virus DNA sequence in colorectal cancers in Japan. Virchows Arch 2005, 447:723-730.
63. Randhawa P., Ho A., Shapiro R., Vats A., Swalsky P., Finkelstein S., et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol 2004, 42:1176-1180.
64. Kahan A.V., Coleman D.V., Koss L.G. Activation of human polyomavirus infection-detection by cytologic technics. Am J Clin Pathol 1980, 74:326-332.
65. Traystman M.D., Gupta P.K., Shah K.V., Reissig M., Cowles L.T., Hillis W.D., et al. Identification of viruses in the urine of renal transplant recipients by cytomorphology. Acta Cytol 1980, 24:501-510.
66. Drachenberg R.C., Drachenberg C.B., Papadimitriou J.C., Ramos E., Fink J.C., Wali R., et al. Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am J Transplant 2001, 1:373-381.
67. Hirsch H.H., Steiger J. Polyomavirus BK. Lancet Infect Dis 2003, 3:611-623.
68. Drachenberg C.B., Papadimitriou J.C., Hirsch H.H., et al. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant 2004, 4:2082-2092.
69. Moll N.M., Rietsch A.M., Ransohoff A.J., Cossoy M.B., Huang D., Eichler F.S., et al. Cortical demyelination in PML and MS: similarities and differences. Neurology 2007, 70(5):336-343.
70. Cinque P., Scarpellini P., Vago L., Linde A., Lazzarin A. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 1997, 11:1-17.
71. Marzocchetti A., Di Giambenedetto S., Cingolani A., Ammassari A., Cauda R., De Luca A. Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy. J Clin Microbiol 2005, 43:4175-4177.
72. Ginevri F., Azzi A., Hirsch H.H., Basso S., Fontana I., Cioni M., et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007, 7(12):2727-2735.
73. Hymes L.C., Warshaw B.L. Polyomavirus (BK) in pediatric renal transplants: evaluation of viremic patients with and without BK associated nephritis. Pediatr Transplant 2006, 10(8):920-922.
74. Kadambi P.V., Josephson M.A., Williams J., Corey L., Jerome K.R., Meehan S.M., et al. Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant 2003, 3(2):186-191.
75. Vats A., Shapiro R., Singh Randhawa P., Scantlebury V., Tuzuner A., Saxena M., et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003, 75(1):105-112.
76. Williams J.W., Javaid B., Kadambi P.V., Gillen D., Harland R., Thistlewaite J.R., et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005, 352(11):1157-1158.
77. Leung A.Y., Chan M.T., Yuen K.Y., Cheng Y.C., Chan K.H., Wong C.L., et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005, 40(4):528-533.
78. Randhawa P.S. Anti-BK virus activity of ciprofloxacin and related antibiotics. Clin Infect Dis 2005, 41(9):1366-1367.
79. Portolani M., Pietrosemoli P., Cermelli C., Mannini-Palenzona A., Grossi M.P., Paolini L., et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Res 1988, 9(3):205-218.
80. Chandraker A., Ali S., Drachenberg C.B., Wali R., Hirsch H.H., DeCaprio S., et al. Use of fluoroquinolones to treat BK infection in renal transplant recipients [abstract]. Am J Transplant 2004, 4(Suppl. 8):587A.
81. Sener A., House A.A., Jevnikar A.M., Boudville N., McAlister V.C., Muirhead N., et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients. Transplantation 2006, 81(1):117-120.
82. Wadei H.M., Rule A.D., Lewin M., Mahale A.S., Khamash A.A., Schwab T.R., et al. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant 2006, 6(5 Pt 1):1025-1032.
83. Antinori A., Cingolani A., Lorenzini P., Giancola M., Uccella I., Bossolasco S., et al. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 2003, 9:47-53.
84. Aksamit A.J. Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neurovirol 2001, 7:386-390.
85. Verma S., Cikurel K., Koralnik I.J., Morgello S., Cunningham-Rundles C., Weinstein Z.R., et al. Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. J Infect Dis 2007, 196:709-711.